These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7843914)

  • 1. Spontaneous development of corneal crystalline deposits in MRL/Mp mice.
    Verhagen C; Rowshani T; Willekens B; van Haeringen NJ
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):454-61. PubMed ID: 7843914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
    Jabs DA; Enger C; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular inflammation in autoimmune MRL/Mp mice.
    Jabs DA; Alexander EL; Green WR
    Invest Ophthalmol Vis Sci; 1985 Sep; 26(9):1223-9. PubMed ID: 4030250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
    Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular inflammation in MRL/Mp-lpr/lpr mice.
    Jabs DA; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1944-7. PubMed ID: 2032814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burns WH; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
    Ratkay LG; Tait B; Tonzetich J; Waterfield JD
    J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis.
    Nose M; Nishimura M; Kyogoku M
    Am J Pathol; 1989 Aug; 135(2):271-80. PubMed ID: 2782373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Band keratopathy in MRL/l and MRL/n mice.
    Hoffman RW; Yang HK; Waggie KS; Durham JB; Burge JR; Walker SE
    Arthritis Rheum; 1983 May; 26(5):645-52. PubMed ID: 6847726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal.
    Suzuki H; Yasukawa K; Saito T; Narazaki M; Hasegawa A; Taga T; Kishimoto T
    Eur J Immunol; 1993 May; 23(5):1078-82. PubMed ID: 8477802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
    Weston KM; Yeh ET; Sy MS
    J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic significance of serum components in the development of autoimmune polyarthritis in MRL/Mp mice bearing the lymphoproliferation gene.
    Itoh J; Nose M; Kyogoku M
    Am J Pathol; 1991 Sep; 139(3):511-21. PubMed ID: 1887861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/MP-lpr/lpr mice.
    Palacios R
    Eur J Immunol; 1984 Jul; 14(7):599-605. PubMed ID: 6430708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous corneal opacities in laboratory mice.
    Van Winkle TJ; Balk MW
    Lab Anim Sci; 1986 Jun; 36(3):248-55. PubMed ID: 3724049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains.
    Jabs DA; Prendergast RA
    Invest Ophthalmol Vis Sci; 1988 Sep; 29(9):1437-43. PubMed ID: 3047079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limiting dilution analysis of interleukin 2 and colony-stimulating factor producer cells in normal and autoimmune mice.
    Hefeneider SH; Conlon PJ; Dower SK; Henney CS; Gillis S
    J Immunol; 1984 Apr; 132(4):1863-8. PubMed ID: 6607951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.